UPDATE : Monday, February 17, 2020
Newly listed biotech firms perform poorly on KOSDAQ by Nam Doo-hyun 2018-10-04 13:09
‘Samsung C&T’s value to rise on BioLogics’ increased value’ by Nam Doo-hyun 2018-10-03 10:11
More doctoral degree holders wanted at biotech ventures by Nam Doo-hyun 2018-10-02 14:40
Which health agency had highest rise in female worker percentage? by Nam Doo-hyun 2018-10-01 13:38
Samil shares jump on anticipation of fatty liver treatment by Nam Doo-hyun 2018-09-28 14:21
Genexine wins nod for immunotherapy trial in combo treatment by Nam Doo-hyun 2018-09-27 11:25
Korea’s drug exports continue to rise in August by Nam Doo-hyun 2018-09-20 14:23
‘Many Korean hospitals operating in China remain unlawful’ by Nam Doo-hyun 2018-09-20 14:22
Shares of newly listed biotech firms surge by Nam Doo-hyun 2018-09-19 18:30
‘If you can’t avoid healthcare regulation, enjoy it’ by Nam Doo-hyun 2018-09-19 14:43
‘Smart hospitals’ to reduce repetitive nursing work by Nam Doo-hyun 2018-09-17 15:48
Nature Cell shares spike despite investment alert warning by Nam Doo-hyun 2018-09-14 16:08
Female workforce scarce in top 15 local pharmaceuticals by Nam Doo-hyun 2018-09-13 11:41
GC Cell shares spike on winning FDA nod for Immuncell-LC by Nam Doo-hyun 2018-09-12 16:05
‘Xgeva reduces risk of bone problems in solid tumor patients’ by Nam Doo-hyun 2018-09-12 12:23
Hepatitis C patients wait for Maviret’s arrival by Nam Doo-hyun 2018-09-11 16:16
‘ToolGen’s KOSDAQ listing might be in peril’ by Nam Doo-hyun 2018-09-10 14:59
Opdivo-Yervoy okayed as first-line treatment for renal cell carcinoma by Nam Doo-hyun 2018-09-06 15:02
CrystalGenomics to export novel drug Acelex to Brazil soon by Nam Doo-hyun 2018-09-04 11:18
Korea’s drug exports to China rebound this year by Nam Doo-hyun 2018-08-31 13:10
Back to Top